INVESTORS.XBIOTECH.COM SERVER
Our crawlers detected that a lone root page on investors.xbiotech.com took five hundred and five milliseconds to load. We could not detect a SSL certificate, so therefore our parsers consider this site not secure.
FAVICON
![](/f/qk9iy7olj6cfahqljeexqqjj/256/investors.xbiotech.com.png)
SITE TITLE
Investor Overview - Xbiotech Investor RelationsDESCRIPTION
Xbiotech is a leading developer of biological therapies including a pipeline of TrueHuman antibodies and biosimilars.PARSED CONTENT
The web page investors.xbiotech.com had the following in the web site, "XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide." I saw that the website stated " XBiotech Completes Enrollment for XilonixTM Phase III Registration Study in Europe." They also said " XBiotech Announces Expansion of Global Phase 3 Registration Study in Europe using XilonixTM for Treatment of Metastatic Colorectal Cancer. There are currently no events scheduled." The meta header had xbiotech as the first optimized keyword. This keyword is followed by biopharmaceutical and biosimilars which isn't as important as xbiotech.